Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45)

NCT00857506 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

152

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease
Mild Cognitive Impairment

Interventions

DRUG: florbetapir F 18

Sponsor

Avid Radiopharmaceuticals